FUNDED RESEARCH FOR 2021-2022
George C. Cotzias Fellowship
The George C. Cotzias Fellowship is named in honor of the scientist who had a critical role in developing Levodopa as a treatment for Parkinson’s disease and is awarded with the purpose of encouraging young neurologists to follow in his footsteps.
Vikram Khurana, MD, PhD
Brigham & Women’s Hospital / Harvard Medical School, Boston, MA
Molecular mechanisms of perturbed mRNA metabolism in alpha-synucleinopathy
Abby L. Olsen, MD, PhD
The Brigham and Women’s Hospital, Boston, MA
Harnessing the untapped therapeutic potential of glia in Parkinson’s disease
Diversity in Parkinson’s Disease Research Grant
The Diversity in Parkinson’s Disease Research Grant is awarded to an investigator studying the health disparities or differences among under-represented PD communities.
Jennifer G. Goldman, MD, MS
Shirley Ryan AbilityLab, Chicago, IL
Understanding utilization of rehabilitation services across diverse populations
Miguel E. Rentería, PhD
Red Mexicana de Bioinformática, Cuernavaca, Morelos, Mexico
Clinical, epidemiological, and cognitive characterization of Parkinson’s disease in the Mexican population
Post-Doctoral Fellowships
This fellowship is awarded to support post-doctoral scientists whose research holds promise to provide new insights into the pathophysiology, etiology, and treatment of PD.
Rachel A. Coleman, PhD
University of Alabama at Birmingham, Birmingham, AL
LRRK2 regulation of glucocerebrosidase activity: role of Rab10 and pathological characterization
Enrico Opri, PhD
Emory University, Atlanta, GA
DBS-induced local evoked potentials for asleep intraoperative functional mapping
Leonardo Parra-Rivas, PhD
University of California San Diego, San Diego, CA
Evaluating α-synuclein pathophysiology in human neurons
Research Grants
This grant is awarded to investigators performing innovative PD research at major academic institutions across the United States.
Constanza J. Cortes, PhD
University of Alabama at Birmingham, Birmingham, AL
Exercise-Mimetics: novel neuroprotectant pathways in Parkinson disease
Xianjun Dong, PhD
The Brigham and Women’s Hospital, Boston, MA
Developing RNA biomarkers of early PD pathology from brain organoids and extracellular vesicles
Rebekah Evans, PhD
Georgetown University, Washington DC
Defining circuit alterations that influence dopaminergic neuron vulnerability in early Parkinson’s disease
Rafiq Huda, PhD
Rutgers University, New Brunswick, NJ
Harnessing astrocyte neuromodulation for alleviating the motor symptoms of Parkinson’s disease
Sunil Kumar, PhD
University of Denver, Denver, CO
Identification of novel targets associated with α-synuclein aggregation
Huiliang Wang, PhD
University of Texas at Austin, Austin, TX
Sono-optogenetic stimulation for Parkinson disease treatment in rats
IN THE NEWS
APDA Awards $1.85 Million in Research Grants.